Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

AnnMarie Liapakis

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Pharmacogenomics|February 9, 2010
Pharmacogenetics of hepatitis C therapyAnnmarie Liapakis, Ira Jacobson
Clinics in Liver Disease|August 27, 2011
Telaprevir user's guideAnnMarie Liapakis, Ira Jacobson
Seminars in Dialysis|December 18, 2018
Pharmacokinetics and important drug-drug interactions to remember when treating advanced chronic kidney disease patients with hepatitis C direct acting anti-viral therapyElizabeth Cohen, AnnMarie Liapakis
Pharmacogenomics|September 13, 2012
Is there clinical utility to IL28B genotype testing in the treatment of chronic hepatitis C virus infection?Annmarie Liapakis, Arun B Jesudian
Clinics in Liver Disease|July 16, 2025
The Liver in Systemic DiseaseAnnMarie Liapakis, Ira M Jacobson
Hepatology (Baltimore, Md.)|June 8, 2013
Impact of rapid point-of-care screening tests for the identification of chronic hepatitis C infectionAnnMarie Liapakis, Joseph K Lim
Hepatology Forum|July 5, 2022
Frailty in liver transplantation: A comprehensive reviewAnnMarie Liapakis, Elizabeth Morris, Sukru Emre
Clinical Liver Disease|May 2, 2019
Treatment of chronic hepatitis C virus infection in patients with end-stage renal disease on hemodialysisYash Mittal, AnnMarie Liapakis, Joseph K Lim
Current Opinion in Organ Transplantation|February 13, 2018
Solid organ transplantation of viral hepatitis C positive donor organs into viral hepatitis C negative recipientsAnnMarie Liapakis, Richard N Formica, Josh Levitsky
Current Transplantation Reports|March 23, 2018
Simultaneous Liver-Kidney Transplantation: Impact on Liver Transplant Patients and the Kidney Transplant Waiting ListClifford D Miles, Scott Westphal, AnnMarie Liapakis, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Pharmacogenomics|February 9, 2010
Pharmacogenetics of hepatitis C therapyAnnmarie Liapakis, Ira Jacobson
Clinics in Liver Disease|August 27, 2011
Telaprevir user's guideAnnMarie Liapakis, Ira Jacobson
Seminars in Dialysis|December 18, 2018
Pharmacokinetics and important drug-drug interactions to remember when treating advanced chronic kidney disease patients with hepatitis C direct acting anti-viral therapyElizabeth Cohen, AnnMarie Liapakis
Pharmacogenomics|September 13, 2012
Is there clinical utility to IL28B genotype testing in the treatment of chronic hepatitis C virus infection?Annmarie Liapakis, Arun B Jesudian
Clinics in Liver Disease|July 16, 2025
The Liver in Systemic DiseaseAnnMarie Liapakis, Ira M Jacobson
Hepatology (Baltimore, Md.)|June 8, 2013
Impact of rapid point-of-care screening tests for the identification of chronic hepatitis C infectionAnnMarie Liapakis, Joseph K Lim
Hepatology Forum|July 5, 2022
Frailty in liver transplantation: A comprehensive reviewAnnMarie Liapakis, Elizabeth Morris, Sukru Emre
Clinical Liver Disease|May 2, 2019
Treatment of chronic hepatitis C virus infection in patients with end-stage renal disease on hemodialysisYash Mittal, AnnMarie Liapakis, Joseph K Lim
Current Opinion in Organ Transplantation|February 13, 2018
Solid organ transplantation of viral hepatitis C positive donor organs into viral hepatitis C negative recipientsAnnMarie Liapakis, Richard N Formica, Josh Levitsky
Current Transplantation Reports|March 23, 2018
Simultaneous Liver-Kidney Transplantation: Impact on Liver Transplant Patients and the Kidney Transplant Waiting ListClifford D Miles, Scott Westphal, AnnMarie Liapakis, et al.
Pageof 4